Routine proteinuria monitoring for bevacizumab in patients with gynecologic malignancies. [electronic resource]
Producer: 20180213Description: 771-776 p. digitalISSN:- 1477-092X
- Adult
- Aged
- Antineoplastic Agents, Immunological -- adverse effects
- Bevacizumab -- adverse effects
- Drug Monitoring -- methods
- Female
- Genital Neoplasms, Female -- diagnosis
- Humans
- Male
- Middle Aged
- Nephrotic Syndrome -- chemically induced
- Proteinuria -- chemically induced
- Retrospective Studies
- Risk Factors
- Urinalysis -- methods
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.